arrow
A

Axel zur Hausen

Maastricht University
H指数:45
被引数:8,935

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification

基于DNA甲基化标志物的系统评价开发透明细胞肾细胞癌预后风险模型:ISUP/WHO 2022分类后的更新

2025-08-180
OAAI
Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells

重症肌无力(Myasthenia gravis)伴AChR抗体,当前对其病理生理学的认识以及针对浆细胞的治疗策略的最新进展

2025-07-100
PRE
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids

基于免疫组织化学分析的肺类癌定义分子亚组的鉴定及其潜在的治疗易感点

2024-11-014
OAAI
Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets
2023-12-282
OAAI